Hardman Johnston Global Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qiagen
QGEN
|
+$104M |
| 2 |
HDFC Bank
HDB
|
+$20.4M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
+$8.8M |
| 4 |
AGN
Allergan plc
AGN
|
+$795K |
| 5 |
NXP Semiconductors
NXPI
|
+$787K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QGENF
QIAGEN NV
QGENF
|
+$104M |
| 2 |
Broadcom
AVGO
|
+$49M |
| 3 |
F5
FFIV
|
+$15.4M |
| 4 |
Fresenius Medical Care
FMS
|
+$12.2M |
| 5 |
ASML
ASML
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.14% |
| 2 | Healthcare | 23.1% |
| 3 | Financials | 11.87% |
| 4 | Consumer Discretionary | 6.3% |
| 5 | Materials | 4.3% |
Similar funds
Hardman Johnston Global Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Hardman Johnston Global Advisors held 79 positions worth $2.23B, up 8.6% from $2.05B the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Hardman Johnston Global Advisors withdrew a net $90.9M in Q1 2017, closing 3 positions and reducing 59 holdings. Its most notable exit was QIAGEN NV, an estimated $104M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Hardman Johnston Global Advisors opened a new position in Qiagen worth $104M.
- Hardman Johnston Global Advisors's largest Q1 2017 buy was Qiagen: 3,369,852 shares worth $104M.
- Hardman Johnston Global Advisors added most to HDFC Bank in Q1 2017, an estimated $20.4M increase.
- Hardman Johnston Global Advisors's biggest Q1 2017 reduction was Broadcom, cutting an estimated $49M.
- Hardman Johnston Global Advisors fully exited QIAGEN NV in Q1 2017, selling an estimated $104M.
- Hardman Johnston Global Advisors's ten largest holdings make up 57% of its $2.23B portfolio in Q1 2017.
- Hardman Johnston Global Advisors opened 2 new positions and closed 3 in Q1 2017.
- Hardman Johnston Global Advisors's portfolio value rose 8.6% quarter-over-quarter to $2.23B.
Based on Hardman Johnston Global Advisors's 13F filing for Q1 2017, filed 10 May 2017.